The longest animal safety studies extended to 6 weeks of repeated dosing
That's your political stance.' When normal people would say f you." Someone in the comments claimed the man had acted like this before

Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms

Final Takeaway: Sermorelin vs BPC-157 Sermorelin and BPC-157 arent competing peptides, theyre designed for different purposes
How often are peptide injections needed
Two Novel Clinical Tests for the Diagnosis of Hip Labral Tears